AgediNicholsonBotoMD

PubMed

• An Uncommon Presentation of Carcinosarcoma of the Stomach and a Minimally Invasive Approach for Treatment.
  Anoush Calikyan, Agedi N Boto, Valeriia Klymenko, Imran M Siddiqui> ;Case Reports in Gastrointestinal Medicine. 2022 Jan 1
• 71 citations
  PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.
  , , , , , , , , , , , , , , , , , > ;Science Translational Medicine. 2019 Dec 11
• 370 citations
  Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy.
  Jun Wang, Jingwei Sun, Linda N. Liu, Dallas B. Flies, Xinxin Nie, Maria I. Toki, Jian-Ping Zhang, Chang Song, Melissa Zarr, Xu Zhou, Xue Han, Kristina A. Archer, Thoma...> ;Nature Medicine. 2019 Mar 4
• 491 citations
  Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
  Jun Wang, Miguel F. Sanmamed, Ila Datar, Tina Tianjiao Su, Lan Ji, Jingwei Sun, Ling Chen, Yusheng Chen, Gefeng Zhu, Weiwei Yin, Linghua Zheng, Ting Zhou, Ti Badri, Sh...> ;Cell. 2019 Jan 10
• 4 citations
  Strong androgen receptor expression can aid in distinguishing GATA3+ metastases
  Agedi Boto, Malini Harigopal> ;Human Pathology. 2018 May 1
• Hormone producing gynecological tumors: pathologic entities and clinical significance.
  Agedi Boto, Pei Hui> ;Expert Review of Endocrinology & Metabolism. 2018 Jan 1
• 64 citations
  Regulation of the NaV1.5 cytoplasmic domain by calmodulin
  Sandra B. Gabelli, Agedi N. Boto, Victoria Halperin Kuhns, Mario A. Bianchet, Federica Farinelli, Srinivas Aripirala, Jesse B. Yoder, Jean Jakoncic, Gordon F. Tomasell...> ;Nature Communications. 2014 Nov 5
• 14 citations
  Structural studies of the Nudix GDP‐mannose hydrolase from E. coli reveals a new motif for mannose recognition
  Agedi N. Boto, WenLian Xu, Jean Jakoncic, Archana Pannuri, Tony Romeo, Maurice J. Bessman, Sandra B. Gabelli, L. Mario Amzel> ;Proteins. 2011 Aug 1
• Join now to see all

Journal Articles

• Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer Immunotherapy  
  David L Rimm, Agedi N Boto, Roy S Herbst, Nature